NCT03232684 is a clinical trial of Rapid on-site evaluation in Intrathoracic Lymphadenopathy, sponsored by Maggiore Bellaria Hospital, Bologna.

Who is sponsoring NCT03232684?

NCT03232684 is sponsored by Maggiore Bellaria Hospital, Bologna.

What drugs are being tested in NCT03232684?

Interventions in NCT03232684: Rapid on-site evaluation.

What condition does NCT03232684 study?

NCT03232684 studies Intrathoracic Lymphadenopathy.

Is NCT03232684 still recruiting?

NCT03232684 is currently completed. Last updated 20 August 2018.

Last reviewed 2018-08-20 · How we verify

NCT03232684

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rapid On-site Evaluation of Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Samples by Pulmonologists

Completed Last updated 20 August 2018

What this trial tests

trial testing Rapid on-site evaluation in Intrathoracic Lymphadenopathy in 200 participants. Completed in 30 June 2018.

Timeline

1 June 2017

Primary endpoint
31 May 2018

30 June 2018

Quick facts

Lead sponsor	Maggiore Bellaria Hospital, Bologna
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 June 2017
Primary completion	31 May 2018
Estimated completion	30 June 2018
Sites	1 location across Italy

Drugs / interventions tested

Rapid on-site evaluation

Conditions studied

Intrathoracic Lymphadenopathy — all drugs for Intrathoracic Lymphadenopathy →

Sponsor

Maggiore Bellaria Hospital, Bologna

Who can join

18 and older, any sex, with Intrathoracic Lymphadenopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is aimed at verifying if a pulmonologist in training can reliably assess the adequacy of EBUS-TBNA samples from intrathoracic lymphadenopathy after a period of training provided by an experienced pathologist.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Rapid on-site evaluation

Trials testing the same drug.

NCT04618874 — US NAB With ROSE Versus US FNAB With no ROSE · NA · completed
NCT03845764 — Can a Pulmonologist Reliably Assess the Tumor Burden on ROSE Slides Obtained From Pulmonary Nodules and Lymphadenopathy · completed

Other Maggiore Bellaria Hospital, Bologna trials

Trials by the same sponsor.

NCT06591234 — Reliability of Internal Jugular Ultrasound : an Observational Transversal Study Conducted Using Images Registered From P · active not recruiting
NCT06563427 — Reliability of Internal Jugular Ultrasound : an Observational Transversal Study (AIJV) · completed
NCT03845764 — Can a Pulmonologist Reliably Assess the Tumor Burden on ROSE Slides Obtained From Pulmonary Nodules and Lymphadenopathy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03232684 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Maggiore Bellaria Hospital, Bologna
Last refreshed: 20 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03232684.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing